Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Cited by (405)

Items 201–300 of 405

  1. Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial
    Nicolas Kerckhove, Julien Scanzi, Bruno Pereira, Denis Ardid, Michel C. Dapoigny · 2017 · BMJ Open
  2. Patients’ Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study
    Stephanie F. Hughes, Alice Sibelli, Hazel Everitt, Rona E Moss-Morris, Trudie Chalder, J Matthew Harvey, Andrea Vas Falcao, Sabine Landau, Gilly O’Reilly, Sula Windgassen et al. · 2020 · Journal of Medical Internet Research
  3. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis
    Hua-Lan Xu, Lili Zou, Mao-bing Chen, Hua X. Wang, Wen-Ming Shen, Qi-han Zheng, Wei-Yan Cui · 2021 · PLoS ONE
  4. A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study
    Elyse R. Thakur, Jordan M. Shapiro, Johanna L. Chan, Mark A. Lumley, Jeffrey A. Cully, Andrea Michele Bradford, Hashem B. El‐Serag · 2018 · Digestive Diseases and Sciences
  5. Using the Rome IV Criteria to Help Manage the Complex IBS Patient
    Lisa D Lin, Lin Chang · 2017 · American Journal of Gastroenterology
  6. Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome
    Brennan Mason Ross Spiegel · 2022 · The American Journal of Gastroenterology
  7. The Mexican consensus on irritable bowel syndrome
    Ramón Carmona-Sánchez, María Eugenia Icaza-Chávez, M.V. Bielsa-Fernández, Octavio Gomez-Escudero, Francisco Bosques‐Padilla, Enrique Coss‐Adame, F. Esquivel-Ayanegui, Ángel Ricardo Flores-Rendón, M.A. González-Martínez, Francisco M. Huerta-Iga et al. · 2016 · Revista de Gastroenterología de México (English Edition)
  8. Troubles somatiques fonctionnels : un modèle cognitif pour mieux les comprendre
    Victor Pitron, Brigitte Ranque, Hélène Vulser, Jean‐Yves Rotgé, Frédéric Limosin, Cédric Lemogne · 2019 · La Revue de Médecine Interne
  9. Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: A secondary analysis of results from a randomized component trial
    Hugo Hesser, Erik Hedman‐Lagerlöf, Perjohan Lindfors, Erik Andersson, Brjánn Ljótsson · 2021 · Behaviour Research and Therapy
  10. Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review
    Sun Jung Oh, Will Takakura, Ali Ranjideh Rezaie · 2020 · Journal of Clinical Medicine
  11. Temporal dynamics of fMRI signal changes during conditioned interoceptive pain-related fear and safety acquisition and extinction
    Franziska Labrenz, Tamás Spisák, Thomas Ernst, Carlos Alexandre Gomes, Harald H. Quick, Nikolai Axmacher, Sigrid Elsenbruch, Dagmar Timmann · 2022 · Behavioural Brain Research
  12. Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives
    Silvana Bonilla, Samuel Nurko · 2018 · Clinical and Experimental Gastroenterology
  13. Psychological factors to predict chronic diarrhea and constipation in Korean high school students
    Ji Young Kim, Myung Ho Lim · 2021 · Medicine
  14. Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial
    Jun Zhao, Min Chen, Xin Wang, Kun Ye, Suhua Shi, Huixia Li, Jianfang Wang, Xiaowei Chen, Jinxia Ni, Qingshuang Wei et al. · 2021 · BMJ Open
  15. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements
    Justin CY Wu, Annie On On Chan, YW Chan, Gordon CL Cheung, TK Cheung, AMBROSE CHI‐PONG KWAN, Vincent KS Leung, Arthur D. P. Mak, Stephen Cho Wing Sze, Raymond S. M. Wong · 2017 · Hong Kong Medical Journal
  16. How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study
    Matthew Krouwel, Kate B Jolly, Sheila Greenfield · 2019 · Complementary Therapies in Medicine
  17. Return on Investment of Enhanced Behavioral Health Services
    Matt Hawrilenko, Casey Smolka, Emily J Ward, Geetu Ambwani, Millard D. Brown, Anita Mohandas, Martin P. Paulus, John Harrison Krystal, Adam Mourad Chekroud · 2025 · JAMA Network Open
  18. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline
    M. Corsetti, P. Whorwell · 2017 · Expert Review of Gastroenterology & Hepatology
  19. Antidepressants vs. Placebo for the Treatment of Functional Gastrointestinal Disorders in Adults: A Systematic Review and Meta-Analysis
    Nana Xiong, Yanping Duan, Jing Wei, Ricarda Mewes, Rainer Leonhart · 2018 · Frontiers in Psychiatry
  20. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Ayşe Elif Özdener-Poyraz, Anastasia M. Rivkin · 2017 · Drug Design Development and Therapy
  21. SYMPOSIUM REPORT: An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 • Las Vegas, Nevada.
    William D. Chey · 2017 · Europe PMC (PubMed Central)
  22. Optimal management of constipation associated with irritable bowel syndrome
    Manuele Furnari, Nicola de Bortoli, Irene Martinucci, Giorgia Bodini, Elisa Marabotto, Alessandro Moscatelli, Lorenzo Del Nero, Matteo Revelli, Edoardo Vincenzo Savarino, Edoardo Giovanni Giannini et al. · 2015 · Therapeutics and Clinical Risk Management
  23. Gas, Bloating, and Belching: Approach to Evaluation and Management.
    John M. Wilkinson, Elizabeth W. Cozine, Conor G. Loftus · 2019 · PubMed
  24. Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial
    Alexandra M. Wright-Hughes, Pei-Loo Ow, Sarah Louise Alderson, Matthew J Ridd, Robbie Foy, Felicity L. Bishop, Matthew Chaddock, Catherine Fernandez, Elspeth Guthrie, Delia Muir et al. · 2025 · Gut
  25. Global patterns of prescription pain medication usage in disorders of gut–brain interactions
    Yuying Luo, Suzi Alves Camey, Shrikant I. Bangdiwala, Olafur Steinn Palsson, Ami David Sperber, Laurie Keefer · 2022 · Neurogastroenterology & Motility
  26. Higher Emotional Awareness Is Associated With Reduced Pain in Irritable Bowel Syndrome Patients: Preliminary Results
    Ryan S. Smith, Gregory D. Gudleski, Richard David Lane, Jeffrey M. Lackner · 2019 · Psychological Reports
  27. Irritable bowel syndrome: current and emerging treatment options.
    Lauren Peyton, Joy Greene · 2014 · PubMed Central
  28. Moxibustion Eases Chronic Inflammatory Visceral Pain In Rats Via MAPK Signaling Pathway In The Spinal Cord
    Yan Huang, Dan Zhang, Zhiyuan Li, Yanting Yang, Lijie Wu, Ji Zhang, Fang-yuan Zhi, Xi-ying Li, Zheng Shi, Jue Hong et al. · 2019 · Journal of Pain Research
  29. Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D
    Aleksandra Grozić, Keaton Coker, Christopher M. Dussik, Marya S. Sabir, Zhela L. Sabir, Arianna Bradley, Lin Zhang, Jin G. Park, Steven Howard Yale, Ichiro Kaneko et al. · 2022 · PLoS ONE
  30. Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double‐blind, placebo‐controlled trial
    Azadeh Sedighnia, Borna Tadayon Najafabadi, Kiandokht Ghamari, Ahmad Ali Noorbala, Naser Ebrahimi Daryani, Ladan Kashani, Shahin Akhondzadeh · 2019 · Journal of Clinical Pharmacy and Therapeutics
  31. Patients’ perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care
    Sibelli, Alice, Moss-Morris, Rona, Chalder, Trudie, Bishop, Felicity L, Windgassen, Sula, Everitt, Hazel · 2018 · British Journal of General Practice
  32. Biopsychosocial Aspects of Adult and Pediatric Disorders of Gut–Brain Interaction
    Sigrid Elsenbruch, Sarah Ballou, Laurie Keefer, Tasha Murphy, Lukas Van Oudenhove, Miranda A.L. van Tilburg, Dipesh Harshvadan Vasant, Rona L. Levy · 2026 · Gastroenterology
  33. Qualitative Validation of a Novel VR Program for Irritable Bowel Syndrome: A VR1 Study
    Brennan Mason Ross Spiegel, Omer Liran, Rebecca Gale, Carine Khalil, Katherine E. Makaroff, Robert A. Chernoff, Tiffany R. Raber, Bianca W. Chang, Nipaporn Pichetshote, Ali Ranjideh Rezaie · 2022 · The American Journal of Gastroenterology
  34. Therapeutic effects of saffron (Crocus sativus) versus fluoxetine on Irritable Bowel Syndrome: A double-blind randomized clinical trial
    Borna Tadayon Najafabadi, Kiandokht Ghamari, Tahereh Kermany Ranjabari, Ahmad Ali Noorbala, Naser Ebrahimi Daryani, Elmira Vanaki, Shahin Akhondzadeh · 2019 · Advances in Integrative Medicine
  35. Hypnotherapy for chronic pelvic pain: A scoping systematic review and meta-analysis
    Yao Coitinho Biurra, Susan Chesterman, David Skvarc, Antonina A Mikocka‐Walus, Subhadra Evans · 2023 · Complementary Therapies in Clinical Practice
  36. Clinical outcomes associated with antidepressant use in inflammatory bowel disease patients and a matched control cohort
    Djibril M. Ba, Sanjay Kumar Yadav, Guodong Liu, DOUGLAS L. LESLIE, Kent E. Vrana, Matthew D. Coates · 2024 · Scientific Reports
  37. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome
    E. Scarpellini, L. Laterza, G. Ianiro, J. Tack, L. Abenavoli, A. Gasbarrini · 2016 · Expert Opinion on Pharmacotherapy
  38. Irritable Bowel Syndrome and Female Patients.
    L. Harris, S. Umar, Noemi J. Baffy, M. Heitkemper · 2016 · Gastroenterology Clinics of North America
  39. Effect of attention bias modification on event‐related potentials in patients with irritable bowel syndrome: A preliminary brain function and psycho‐behavioral study
    Jun Tayama, Tatsuo Saigo, Sayaka Ogawa, Atsushi Takeoka, Toyohiro Hamaguchi, K. Inoue, H. Okamura, J. Yajima, Ko Matsudaira, Shin Fukudo et al. · 2018 · Neurogastroenterology & Motility
  40. The Effects of Psychological Interventions on Symptoms and Psychology of Functional Dyspepsia: A Systematic Review and Meta-Analysis
    Zhongcao Wei, Xin Xing, Xinxing Tantai, Cailan Xiao, Qian Yang, Xiaosa Jiang, Yujie Hao, Na Liu, Yan Wang, Jinhai Wang · 2022 · Frontiers in Psychology
  41. Efficacy of whole system ayurveda protocol in irritable bowel syndrome – A Randomized controlled clinical trial
    Teja Devendra Naik, Basavaraj R. Tubaki, Devayani S. Patankar · 2022 · Journal of Ayurveda and Integrative Medicine
  42. The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling
    Hugo Hesser, Erik Hedman‐Lagerlöf, Perjohan Lindfors, Erik Andersson, Brjánn Ljótsson · 2017 · Psychological Medicine
  43. Untitled work
    2009 · 10.4166/kjg.2019.73.2.84
  44. Psychological Features in the Inflammatory Bowel Disease–Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors
    Megan L Petrik, Brooke E. Palmer, A. Khoruts, Byron P. Vaughn · 2021 · Crohn's & Colitis 360
  45. Emotional dysregulation in adolescents with functional gastrointestinal disorders
    Burcu Güven, Fulya Gülerman, Ebubekir Akyüz, Gözde Aydın · 2020 · Arab Journal of Gastroenterology
  46. Functional Bowel Disease.
    A. Aboubakr, M. Cohen · 2021 · Clinics in Geriatric Medicine
  47. Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome
    Guanqun Chao, Zhaojun Wang, Shuo Zhang · 2021 · Journal of Inflammation Research
  48. Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome
    Hannah J. Holmes, Elyse R. Thakur, Jennifer N. Carty, Maisa S. Ziadni, Heather K. Doherty, Nancy A. Lockhart, Howard H. Schubiner, Mark A. Lumley · 2018 · General Hospital Psychiatry
  49. Defense Mechanisms in Patients with Irritable Bowel Syndrome and Their Relationship with Symptom Severity and Quality of Life
    Fahimeh Saeed, Mansour Salehi, Kaveh Alavi, Hossein Ajdarkosh, Fatemeh Kashaninasab, Farnaz Nasr Esfahani · 2019 · Middle East Journal of Digestive Diseases
  50. Concurrent functional gastrointestinal disorders in patients with inflammatory bowel disease
    Caroline H. Walker, Anna J. Boland, A Carroll, Anthony O’Connor · 2022 · Frontiers in Gastroenterology
  51. Psychosomatic Practice in Gastroenterology: New Insights and Models from China
    Jianxin Cao, Lixin Ding · 2019 · Psychotherapy and Psychosomatics
  52. Understanding and Managing IBS and CIC in the Primary Care Setting.
    Brooks D. Cash · 2018 · Europe PMC (PubMed Central)
  53. Beneficial effects of Camelina sativa oil on behavioural (memory, anxiety, depression and social-related) manifestations and oxidative stress parameters in a mice model of irritable bowel syndrome
    Roxana Oana Cojocariu, Ioana-Miruna Balmuș, Radu Marian Lefter, Luminiţa Diana Hrițcu, Dana Ababei, Alin Stelian Ciobica, Simona Copaci, Lucian Octav Copolovici, Dana Maria Copolovici, Ștefana Jurcoane · 2020 · ROMANIAN BIOTECHNOLOGICAL LETTERS
  54. The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
    Patricia Sanz Morales, Anisha Wijeyesekera, Margaret Denise Robertson, Peter Philip James Jackson, Glenn R. Gibson · 2022 · Microorganisms
  55. Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management
    Hans Törnblom, Douglas A. Drossman · 2016 · Handbook of experimental pharmacology
  56. Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile
    Kamesh Gupta, Harparam Singh Ghuman, Shivani Handa · 2017 · Clinical Medicine Insights Gastroenterology
  57. Efficacy of a Quebracho, Conker Tree, and M. balsamea Willd Blended Extract in a Randomized Study in Patients with Irritable Bowel Syndrome with Constipation
    K. Brown, Brandi Scott-Hoy, L. Jennings · 2015 · Journal of Gastroenterology and Hepatology Research
  58. The Role of Virtual Reality in the Management of Irritable Bowel Syndrome
    Karisma K. Suchak, Christopher V. Almario, Omer Liran, Robert A. Chernoff, Brennan Mason Ross Spiegel · 2024 · Current Gastroenterology Reports
  59. Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology
    Ioanna Aggeletopoulou, Georgios Geramoutsos, Ploutarchos Pastras, Christos K Triantos · 2025 · Nutrients
  60. Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT
    Alexandra M. Wright-Hughes, Alexander Charles Ford, Sarah Louise Alderson, Pei Loo Ow, Matthew J Ridd, Robbie Foy, Felicity L. Bishop, Matthew Chaddock, Heather Cook, Deborah Cooper et al. · 2024 · Health Technology Assessment
  61. Acid Suppression for Management of Gastroesophageal Reflux Disease: Benefits and Risks
    Carmelo Scarpignato, Luigi Gatta · 2018 · Springer eBooks
  62. Evolution and significance of the psychosomatic model in gastroenterology
    Qiaoli Zhang, Lixin Ding, Jianxin Cao · 2022 · General Psychiatry
  63. Approach to the Patient with Abdominal Pain
    Pankaj Jay Pasricha · 2008
  64. Hyaluronic acid and chondroitin sulfate-based medical devices: formulations, esophageal mucosal protection, and their place in the management of GERD
    Carmelo Scarpignato, Nicola de Bortoli, Paola Iovino, Andrea Nacci, Giovanni Sarnelli, Edoardo Vincenzo Savarino · 2025 · Therapeutic Advances in Gastroenterology
  65. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial
    Judith Zeevenhooven, Clara Marieke Andrea de Bruijn, Arine M. Vlieger, Max Nieuwdorp, Marc Alexander Benninga · 2020 · BMJ Paediatrics Open
  66. The gut microbiome: Potential innovations for the understanding and treatment of psychopathology.
    Matilda E. Nowakowski, Randi E. McCabe, Karen Rowa, Joe Pellizzari, Michael Gordon Surette, Paul Moayyedi, Rebecca Anglin · 2016 · Canadian Psychology/Psychologie canadienne
  67. New therapies in Irritable Bowel Syndrome: what works and when
    O. Craig · 2018 · Current Opinion in Gastroenterology
  68. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial
    Shino Kikuchi, Yuki Oe, Yohei Sasaki, Hirono Ishii, Yuri Ito, Masaru Horikoshi, Takashi Sozu, Hiroshi Seno, Toshi A. Furukawa · 2020 · BMC Gastroenterology
  69. Estrés, depresión, ansiedad y el hábito alimentario en personas con síndrome de intestino irritable
    Mayra Sofía Vergara Alvira, Laura Marcela Ahumada Ossa, Elpidia Poveda · 2022 · Revista Colombiana de Gastroenterología
  70. Stress and the Gastrointestinal System
    Bruno L. Bonaz · 2016 · Springer eBooks
  71. Letter: meta‐analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply
    Alexander Charles Ford, Lucinda A. Harris, Brian E. Lacy, Eamonn M.M. Quigley, Paul Moayyedi · 2019 · Alimentary Pharmacology & Therapeutics
  72. Antidepressants for irritable bowel syndrome.
    Paul Fritsch, Michael R. Kolber, Christina S. Korownyk · 2020 · PubMed Central
  73. Transcutaneous electric nerve stimulation over acupoints for patients with diarrhea-predominant irritable bowel syndrome
    Bo-yu Han, Qianfeng Shao, Yu Cong, Song Guo, Xinyong Mao, Ruhan Wei, Wei Wei · 2018 · Medicine
  74. Current and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome
    Akhil Munjal, B. Dedania, B. Cash · 2019 · Expert Opinion on Pharmacotherapy
  75. Algo-dysfunctional syndromes: a critical digest of the recent literature.
    Rossella Talotta, Fabiola Atzeni, Laura Maria Bazzichi, Camillo Giacomelli, Manuela Di Franco, Fausto Salaffi, Piercarlo Sarzi‐Puttini · 2015 · PubMed
  76. Nerva, a mobile application of gut-directed hypnotherapy for irritable bowel syndrome: User characteristics, patterns of use, and predictors of persistence
    Lauren Simicich, Vanessa Muñiz, Katherine Scheffrahn, Gary R. Elkins · 2024 · Digital Health
  77. Clinical outcomes of patients seen by psychiatrists in a multidisciplinary clinic for disorders of gut‐brain interaction
    Evangelia Dendrinos, Hannah H. Kim, Daniel John Hubik, Jessica Emily Green, Linda Yang, Annalise Stanley, Michael R Salzberg, Michael A. Kamm, Chamara Basnayake · 2025 · Internal Medicine Journal
  78. Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome
    Deepak Chandra Joshi, Neha Raina, Nirmal Joshi, Kajal Gurow, Jyoti Gwasakoti, Abhilasha Sood, Arpit Mehrotra, Hardeep Singh Tuli, Keshav Raj Paudel, Madhu Gupta · 2025 · Archiv der Pharmazie
  79. Síndrome del intestino irritable: lo (pen)último sobre lo que se está investigando
    Juan José Sebastián Domingo · 2015 · Medicina Clínica
  80. Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol
    Chamara Basnayake, Michael A. Kamm, Michael R Salzberg, Angela J. Khera, Danny Liew, Kathryn Burrell, Amy L Wilson-O'Brien, Annalise Stanley, Nicholas J. Talley, Alexander J. V. Thompson · 2019 · Contemporary Clinical Trials
  81. Association between disturbance of self-organization and irritable bowel syndrome in Japanese population using the international trauma questionnaire
    Tomoko Sakuma, Tomohiko Muratsubaki, Michiko Kano, Motoyori Kanazawa, Shin Fukudo · 2024 · Scientific Reports
  82. The role of incongruence between the perceived functioning by patients and clinicians in the detection of psychological distress among functional and motor digestive disorders
    Amanda Rodríguez‐Urrutia, Francisco José Eiroá‐Orosa, Anna M. Accarino, Carolina Malagelada, Fernando Azpiroz · 2017 · Journal of Psychosomatic Research
  83. Improving clinical care for patients with irritable bowel syndrome
    Julie Thompson · 2017 · British Journal of Nursing
  84. The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study
    Rok Seon Choung, Yuri A. Saito, Cathy D. Schleck, William Scott Harmsen, Alan R. Zinsmeister, Joseph A. Murray, Nicholas Joseph Talley · 2021 · Mayo Clinic Proceedings
  85. Irritable Bowel syndrome and Psychiatric Comorbidities: A narrative review
    Ankita Saroj, Adarsh Tripathi, Sumit Rungta · 2022 · Indian Journal of Behavioural Sciences
  86. How do people with refractory irritable bowel syndrome perceive hypnotherapy: Qualitative study protocol
    Matthew Krouwel, Kate B Jolly, Sheila Greenfield · 2019 · European Journal of Integrative Medicine
  87. New regimen for treatment of irritable bowel syndrome with emphasis on Sulpride as the sole maintenance therapy
    Kamel El-Reshaid, Shaikha Al-Bader · 2019 · Journal of Drug Delivery and Therapeutics
  88. Therapeutisches Management der chronischen Obstipation
    Daniel Pohl, Jan Levenfus, Michel Adamina, Sandra Capraru, Henriette Sophie Heinrich, Claudia Krieger‐Grübel, Ioannis Linas, Sophie Restellini, Radu I. Tutuian · 2022 · Schweizer Gastroenterologie
  89. The Effectiveness of Emotion-Focused Therapy on Rumination, Alexithymia, and Sleep Quality in Woman with Irritable Bowel Syndrome
    Maryam Dana, Farnaz Keshavarzi Arshadi, Fariba Hassani, Parvaneh Mohammadkhani · 2023
  90. Predictors of Treatment Success of Psychotherapy in Functional Disorders: A Systematic Review of the Literature
    Caroline Rometsch, Alexandra Martin, Fiammetta Cosci · 2025 · Clinical Psychology & Psychotherapy
  91. Irritable Bowel Syndrome
    Patrick J. Hanaway · 2017 · Elsevier eBooks
  92. Scientific Evidence for the Treatment of Children with Irritable Bowel Syndrome
    Paolo Quitadamo, Sara Isoldi, Saverio Mallardo, Letizia Zenzeri, Giovanni Di Nardo · 2021 · Current Pediatric Reviews
  93. Complementary, Integrative, and Holistic Medicine: Integrative Approaches to Pediatric Irritable Bowel Syndrome
    Alycia Leiby, Minal Vazirani · 2016 · Pediatrics in Review
  94. Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn
    Sarah L Marsden, Alexander Charles Ford · 2016 · The American Journal of Gastroenterology
  95. Changing Beliefs About Emotions in IBS: A Single Case Design
    Hannah M. Bowers, Abigail L. Wroe · 2018 · Behavioural and Cognitive Psychotherapy
  96. Applying Best Practice Guidelines on Chronic Pain in Clinical Practice—Treating Patients Who Suffer From Pain and Addiction
    Keith G. Heinzerling · 2018 · Elsevier eBooks
  97. Psychiatric Issues in Older Adults with Gastrointestinal Disorders
    Rafael Gonzalez-Alonso, Maria Fernanda Gomez, Mary Alice O’Dowd · 2021 · Springer eBooks
  98. New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms—Pilot study with a 12 month follow-up
    Maximilian Hinse, Anja Thronicke, Anne Berghöfer, Harald Matthes · 2022 · PLoS ONE
  99. Extinguishing Fear of Gastrointestinal Symptoms to Treat Functional Gastrointestinal Disorders
    Laurie Keefer · 2016 · Clinical Gastroenterology and Hepatology
  100. Irritable Bowel Syndrome
    A. Ford · 2019 · Evidence-based Gastroenterology and Hepatology 4e